Biocompatible surgical compositions

1. A biocompatible adhesive macromer composition comprising:

an isocyanate-functional methoxy polyethylene glycol combined with at least one multi-functional isocyanate; and

a polyamino functional compound possessing multiple primary amines,

wherein the isocyanate-functional methoxy polyethylene glycol includes degradable linkages and has pendant polyalkylene oxide groups, and

wherein the biocompatible adhesive macromer composition further comprises an enzyme which increases the degradation rate of the biocompatible macromer composition.

2. A biocompatible adhesive macromer composition as in claim 1 , wherein the at least one multi-functional isocyanate is selected from the group consisting of diisocyanates, triisocyanates and combinations thereof.

3. A biocompatible adhesive macromer composition as in claim 1 , wherein the at least one multi-functional isocyanate is a diisocyanate selected from the group consisting of toluene diisocyanate, xylylene diisocyanate, bisphenylene diisocyanate, 4,4′-oxybis(phenyl isocyanate), lysine diisocyanate, 2,4,6-trimethyl-1,3-phenylene diisocyanate, naphthylene diisocyanate, diphenylmethane diisocyanate, trimethylene diisocyanate, tetramethylene diisocyanate, pentamethylene diisocyanate, hexamethylene diisocyanate, ethylethylene diisocyanate, trimethylhexane diisocyanate, heptanemethylene diisocyanate, butane diisocyanate, and combinations thereof.

4. A biocompatible adhesive macromer composition as in claim 1 , wherein the at least one multi-functional isocyanate is a triisocyanate selected from the group consisting of triphenylmethane triisocyanate, tris(isocyanatophenyl) thiophosphate, lysine ester triisocyanate, 1,6,11-undecane triisocyanate, 1,3,6-hexamethylene triisocyanate, 1,8-diisocyanato-4-isocyanatomethyloctane, bicycloheptane triisocyanate, and combinations thereof.

5. A biocompatible adhesive macromer composition as in claim 1 , wherein the polyamino functional compound possessing multiple primary amines is selected from the group consisting of ethylene diamine, hexamethylene diamine, lysine, diethylene triamine, triethylene tetramine, tetraethylene pentamine, bishexamethylene triamine, N,N′-bis(3-aminopropyl)-1,2-ethane diamine, N-(3-aminopropyl)-1,3-propane diamine, N-(2-aminoethyl)-1,3propane diamine, N-(3-aminopropyl)-1,4-butane diamine, N,N′-bis(3-aminopropyl)-1,4-butane diamine, cyclohexane diamine, isomers of cyclohexane diamine, 4,4′-methylene biscyclohexane amine, 4′4′-methylene bis(2-methylcyclohexanamine), toluene diamine, phenylene diamine, isophorone diamine, phenalkylene polyamine, polyoxyalkylene amines, and polypeptides.

6. A biocompatible adhesive macromer composition as in claim 1 , wherein the biocompatible macromer composition includes a biologically active agent.

7. A biocompatible adhesive macromer composition as in claim 1 , wherein the biocompatible macromer composition includes a medicinal agent.

8. A method for closing a wound comprising:

applying the biocompatible adhesive macromer composition of claim 1 to said wound; and

allowing the biocompatible adhesive macromer composition to set thereby closing said wound.

9. The method of claim 8 wherein the wound is a surgical incision.

10. A method for filling a void in animal tissue comprising:

applying the biocompatible adhesive macromer composition of claim 1 to said void; and

allowing the biocompatible adhesive macromer composition to set thereby filling said void.

11. A method for adhering a medical device to a surface of animal tissue comprising the steps of:

applying the biocompatible adhesive macromer composition of claim 1 to said device, said surface or both;

bringing the device, biocompatible adhesive macromer composition and surface into contact with each other; and

allowing the biocompatible adhesive macromer composition to set thereby adhering the device and surface to each other.

12. The method of claim 11 wherein said medical device is an implant.